CULLINAN THERAPEUTICS, INC. (CGEM) Net income 2020–2025
CULLINAN THERAPEUTICS, INC. (CGEM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$219.9MFY2025 · since FY2020: -$51.8M → -$219.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$219.9M | -31.4% |
| FY2024 | -$167.4M | -9.3% |
| FY2023 | -$153.2M | -237.7% |
| FY2022 | $111.2M | +269.6% |
| FY2021 | -$65.6M | -26.6% |
| FY2020 | -$51.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CGEM financial trends
CGEM RevenueCGEM Net marginCGEM Gross profitCGEM Gross marginCGEM Operating incomeCGEM Operating marginCGEM Operating cash flowCGEM Free cash flowCGEM Capital expendituresCGEM Return on equityCGEM Stock buybacksCGEM Dividends paidCGEM Total assetsCGEM Total liabilitiesCGEM Shareholders’ equityCGEM overview →